{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-029676","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2022-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.994495+00:00","generated_at":"2026-06-27T01:58:46.734533+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"TELA Bio launches SiteGuard No Rinse Antimicrobial Solution for plastic reconstructive surgery","bullets":["SiteGuard uses Next Science's XBIO Technology to deconstruct biofilm and provide over 5 hours of protection.","TELA Bio entered exclusive distribution agreement in November 2021 to market the wash in US plastic reconstructive surgery.","First adjunctive soft-tissue technology complementing TELA's soft-tissue preservation and restoration product portfolio.","CEO Antony Koblish cites encouraging early test market experience and plans for nationwide expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-029676","json":"https://secwatch.observer/filing/0001104659-22-029676.json","markdown":"https://secwatch.observer/filing/0001104659-22-029676.md","text":"https://secwatch.observer/filing/0001104659-22-029676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465922029676/0001104659-22-029676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465922029676/tm228184d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:58:46.734533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}